Nova Patents
AT221574T

The cytoplasmic inhibition of gene expression

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

207 members in 18 offices

This recordMember, by publication datePriority claim8 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
26054694United States of AmericaA
9506741United States of AmericaW

Members207

Family members, oldest first
DocumentOfficeKind
WO8908145A1World Intellectual Property Organization (WIPO)A1
AU4072589AAustraliaA
WO9000611A1World Intellectual Property Organization (WIPO)A1
AU3975089AAustraliaA
CA2000114A1CanadaA1
EP0363792A1European Patent Office (EPO)A1
WO9004029A1World Intellectual Property Organization (WIPO)A1
AU4418989AAustraliaA
ZA897501BSouth AfricaB
WO9013654A1World Intellectual Property Organization (WIPO)A1
AU5664090AAustraliaA
KR900702037ARepublic of KoreaA
EP0406267A1European Patent Office (EPO)A1
JPH03502886AJapanA
CA2086417A1CanadaA1
CA2166818A1CanadaA1
WO9200373A1World Intellectual Property Organization (WIPO)A1
AU8295491AAustraliaA
CA2114636A1CanadaA1
WO9303161A1World Intellectual Property Organization (WIPO)A1
AU3351193AAustraliaA
KR930701589ARepublic of KoreaA
EP0547065A1European Patent Office (EPO)A1
AU638411B2AustraliaB2
EP0547065A4European Patent Office (EPO)A4
JPH06500011AJapanA
EP0596979A1European Patent Office (EPO)A1
US5316931AUnited States of AmericaA
KR940005597B1Republic of KoreaB1
EP0596979A4European Patent Office (EPO)A4
CA2152934A1CanadaA1
WO9416089A1World Intellectual Property Organization (WIPO)A1
AU5987194AAustraliaA
IL108241D0IsraelD0
EP0363792B1European Patent Office (EPO)B1
IL111608D0IsraelD0
AT117376TAustriaT
ATE117376T1AustriaT1
ZA939798BSouth AfricaB
DE68920685D1GermanyD1
JPH07503361AJapanA
ES2069560T3SpainT3
CA2176236A1CanadaA1
WO9513386A2World Intellectual Property Organization (WIPO)A2
DE68920685T2GermanyT2
AU1173495AAustraliaA
CA2000114CCanadaC
WO9513386A3World Intellectual Property Organization (WIPO)A3
IL113955D0IsraelD0
EP0677113A1European Patent Office (EPO)A1
CA2193094A1CanadaA1
CA2309028A1CanadaA1
WO9534668A2World Intellectual Property Organization (WIPO)A2
AU2653495AAustraliaA
IL115578D0IsraelD0
KR960700344ARepublic of KoreaA
WO9534668A3World Intellectual Property Organization (WIPO)A3
ZA954451BSouth AfricaB
ZA948973BSouth AfricaB
AU3010695AAustraliaA
CA2202652A1CanadaA1
WO9612028A1World Intellectual Property Organization (WIPO)A1
ZA958659BSouth AfricaB
AU3763795AAustraliaA
JPH08505289AJapanA
US5529909AUnited States of AmericaA
EP0731843A1European Patent Office (EPO)A1
CA2223493A1CanadaA1
WO9640867A1World Intellectual Property Organization (WIPO)A1
AU6157296AAustraliaA
US5589367AUnited States of AmericaA
US5631151AUnited States of AmericaA
MX9606476AMexicoA
JPH09505468AJapanA
MX9702714AMexicoA
EP0787195A1European Patent Office (EPO)A1
EP0804600A1European Patent Office (EPO)A1
AU683412B2AustraliaB2
KR970707291ARepublic of KoreaA
IS4629AIcelandA
JPH10501968AJapanA
EP0832191A1European Patent Office (EPO)A1
CA1339841CCanadaC
IL122412D0IsraelD0
AU694102B2AustraliaB2
AU695044B2AustraliaB2
KR0149181B1Republic of KoreaB1
JPH10508468AJapanA
US5811653AUnited States of AmericaA
US5814495AUnited States of AmericaA
US5837505AUnited States of AmericaA
CA1340378CCanadaC
US5866785AUnited States of AmericaA
KR19990022818ARepublic of KoreaA
US5889190AUnited States of AmericaA
US5889191AUnited States of AmericaA
JPH11507217AJapanA
CA2086417CCanadaC
US5922602AUnited States of AmericaA
AU710588B2AustraliaB2
Showing 100 of 207